Kester to co-direct nanoSTAR

Nano-medicine expert to improve cross-grounds collaboration for nano-research by Savannah Borders | Mar 02 2014 | 21 hours ago

Dr. Mark Kester will co-direct the Universitys Institute for Nanoscale and Quantum Scientific and Technological Advanced Research, the University announced last week. The institute, nicknamed nanoSTAR, uses both graduate and undergraduate students and provides opportunities for cross-school collaboration for University researchers.

An expert in nanomedicine, Kester was the inaugural director of the Penn State Center for NanoMedicine and Materials, as well as the former chair of pharmacology there. Kester was brought to the University at the beginning of the year as a pharmacology professor.

Dr. Stu Wolf, the current director of nanoSTAR, said he is excited to have Dr. Kester on board as a co-director because of the connections he brings that will help fulfill the institutes cross-discipline focus.

One of the real motivations of the center was to bring together people from the different schools, Wolf said. We provide funding to support faculty to do research in this area. The requirement for any faculty to receive funding is that they have to be collaborating with a faculty member from another school.

Wolf said Kesters connections will help foster a stronger relationship between engineering research and medical research.

The beauty of U.Va. is the Grounds themselves; the engineering and sciences are well-connected already to the college of medicine, Kester said. The NanoSTAR Institute is already formed at U.Va., and what I am looking forward to do is working with Stu Wolf and taking the NanoSTAR to the next level to rebrand and reinvent the nanoSTAR to truly have a strong medical and biomedical focus

Kester brings previous experience in large-scale research to his leadership role, particularly the sandbox model at Penn State, where engineers, research scientists and medical doctors collaborated to develop innovative and useful technologies.

The reason I came to U.Va. is really to expand and exploit all the great technology that are being developed across the ground at U.Va., Kester said, and to really take some of these new advances and new materials and new nano-technologies, and show they have a medical and biomedical applications.

Kester said materials take on new properties at a nanoscale. The exploitation of these properties allows for large advancements in useful treatments.

See the original post:

Kester to co-direct nanoSTAR

In first moments of infection, a division and a decision

PUBLIC RELEASE DATE:

2-Mar-2014

Contact: Scott LaFee slafee@ucsd.edu 619-543-6163 University of California - San Diego

Using technologies and computational modeling that trace the destiny of single cells, researchers at the University of California, San Diego School of Medicine describe for the first time the earliest stages of fate determination among white blood cells called T lymphocytes, providing new insights that may help drug developers create more effective, longer-lasting vaccines against microbial pathogens or cancer.

The findings are published in the March 2, 2014 online issue of Nature Immunology.

Nave T lymphocytes patrol the front lines of the human bodys defense against infection, circulating in blood and tissues, searching for invasive microbes and other foreign antigens. Theyre called nave because they have not yet encountered an invader. When they do, these T cells activate and divide, giving rise to two types of daughter cells: effector lymphocytes responsible for immediate host defense and memory lymphocytes that provide long-term protection from similar infections.

Researchers have been trying for a very long time to understand when and how T lymphocytes give rise to effector and memory cells during an infection, said John T. Chang, MD, assistant professor in the Department of Medicine and the studys co-principal investigator, along with Gene W. Yeo, PhD, assistant professor in the Department of Cellular and Molecular Medicine and Institute for Genomic Medicine.

However, all studies up to this point were based on analyses on bulk populations of cells, making it impossible to understand fate decisions made by individual cells. First authors Janilyn Arsenio, a postdoctoral fellow in the Chang lab and Boyko Kakaradov, a graduate student in the Yeo lab and UCSD Bioinformatics graduate program said that they took advantage of recent technological advances in single-cell gene expression profiling and cutting-edge machine-learning algorithms to address this question on a level of detail that was not previously possible.

Chang, Yeo and colleagues discovered that the decision by an individual T cell to produce effector and memory cells is made almost at the moment of infection. The mother lymphocyte seems to divide into two daughter cells that are already different from birth, said Chang, with one becoming an effector cell while its sister becomes a memory cell.

Chang noted that the primary purpose of vaccines is to produce strong and durable immune protection, which depends heavily upon generation of memory lymphocytes. Our work suggests that the way T lymphocytes divide early during a microbial infection might be critical to whether or not they give rise to long-lived memory cells. Strategies that improve this process could potentially enhance durable immunity and help us to design more effective vaccines.

View post:

In first moments of infection, a division and a decision

Tips for Taking Better Photos with your Smartphone

YouTube Videos Tweets Comments

It is a mistake if your phone will take photos the same quality, as it is the case with cameras. However, you can learn to make the best out of it and make the perfect photos with your smartphone.

The number one problem that smartphones have is with the flash, because it cannot live up to the one that cameras have. That is why you need to learn how to do it without the help of the flash. Here are some of the tips for taking better photos with your smartphone:

Triszia Marie Santos Triszia Marie Santos is navigating the mobile device space for you. She is an early adopter in all things mobile and loves to write about the latest mobile trends.

Read more from the original source:

Tips for Taking Better Photos with your Smartphone

PRESS RELEASE: Eckert & Ziegler Awards Travel Grants to Young Scientists in Nuclear Medicine

PRESS RELEASE: Eckert & Ziegler Awards Travel Grants to Young Scientists in Nuclear Medicine

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Miscellaneous Eckert & Ziegler Awards Travel Grants to Young Scientists in Nuclear Medicine

03.03.2014 / 10:19

=--------------------------------------------------------------------

Press Release

Eckert & Ziegler Awards Travel Grants to Young Scientists in Nuclear Medicine

Berlin, March 3, 2014. The Eckert & Ziegler Abstract Award is entering its seventh year. Young scientists can enter the competition with their innovative scientific research in the field of nuclear medicine. The deadline for submission is April 28, 2014. Each year, the Eckert & Ziegler Abstract Award supports young scientists and PhD students who would like to present their findings to a wider audience at the annual congress of the European Association of Nuclear Medicine (EANM) in October 2014. Five travel grants of EUR 1,000 each will be awarded by Eckert & Ziegler, one of the leading manufacturers of isotope products in Europe, and the European Association of Nuclear Medicine (EANM). The jury consists of a panel of independent, unbiased EANM experts. The five winners will receive their awards on October 22, 2014 at the EANM Annual Congress in Gothenburg, Sweden.

Not only are the awards entering their seventh year, they are also gaining increasing popularity in the industry. Last year, almost 600 young scientists from all over the world entered the competition in the hope of winning the coveted award.

"Nuclear medicine has huge potential as it can be used to diagnose diseases non-invasively, which would be impossible or very difficult to detect with other methods. It helps patients in terms of early diagnosis and in deciding on a targeted therapy. This is why we hope to help ensure with these awards that the substantial progress in medical imaging can soon be transformed into more precise, faster or less expensive methods of diagnosis and therapy," commented Karolin Riehle, spokeswoman for Eckert & Ziegler AG.

Eligibility for Participation All EANM members who are not older than 38 years of age at the time of submission are eligible to participate. Applications can be submitted electronically at http://eanm14.eanm.org. The submission deadline is April 28, 2014.

Go here to read the rest:

PRESS RELEASE: Eckert & Ziegler Awards Travel Grants to Young Scientists in Nuclear Medicine

Last Voice For Liberty Network and NWO Truth present: While you were sleeping- Truth Emerges – Video


Last Voice For Liberty Network and NWO Truth present: While you were sleeping- Truth Emerges
Audio Copyright 2014 AlbinoRaccoon420 We do not own any music used in this program All images,sound clips, and music are used for educational purposes only F...

By: LastVoiceForLiberty

Read the original here:

Last Voice For Liberty Network and NWO Truth present: While you were sleeping- Truth Emerges - Video